| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.2 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |